Efficacy of Ibrutinib in the Treatment of Monoclonal Gammopathy of Renal Significance with C3 Deposits Secondary to Chronic Lymphocytic Leukemia. (2025). Archives of Clinical and Biomedical Research, 9(5), 360-363. https://fortunejournals.org/ojs/index.php/acbr/article/view/15131